SEARCH

SEARCH BY CITATION

References

  • 1
    Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:15461554.
  • 2
    Monedero P, García-Fernández N, Pérez-Valdivieso JR, Vives M, Lavilla J. Acute kidney injury. Rev Esp Anestesiol Reanim 2011; 58:365374.
  • 3
    de Mendonça A, Vincent JL, Suter PM et al. Acute kidney injury in the ICU: risk factors and outcome evaluated by the SOFA score. Intens Care Med 2000; 26:915921.
  • 4
    Simmons EM, Himmelfarb J, Sezer MT et al., PICARD Study Group. Plasma cytokine levels predict mortality in patients with acute kidney injury. Kidney Int 2004; 65:13571365.
  • 5
    Liaño F, Junco E, Pascual J, Madero R, Verde E. The spectrum of acute kidney injury in the intensive care unit compared with that seen in other settings. The Madrid Acute Kidney Injury Study Group. Kidney Int Suppl 1998; 66:S1624.
  • 6
    Garzotto F, Piccinni P, Cruz D et al., NEFROINT Investigation Group. RIFLE-based data collection/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit. Blood Purif 2011; 31:159171.
  • 7
    Flo TH, Halaas O, Torp S et al. Differential expression of Toll-like receptor 2 in human cells. J Leukoc Biol 2001; 69:474481.
  • 8
    Dybdahl B, Wahba A, Lien E et al. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through Toll-like receptor-4. Circulation 2002; 105:685690.
  • 9
    Giannoudis PV, Harwood PJ, Loughenbury P, Van Griensven M, Krettek C, Pape HC. Correlation between IL-6 levels and the systemic inflammatory response score: can an IL-6 cutoff predict a SIRS state? J Trauma 2008; 65:646652.
  • 10
    Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute kidney injury. J Am Soc Nephrol 2003; 14:21992210.
  • 11
    Zibar L, Wagner J, Pavlinić D et al. The relationship between interferon-γ gene polymorphism and acute kidney allograft rejection. Scand J Immunol 2011; 73:319324.
  • 12
    Karimi MH, Daneshmandi S, Pourfathollah AA et al. A study of the impact of cytokine gene polymorphism in acute rejection of renal transplant recipients. Mol Biol Rep 2012; 39:509515.
  • 13
    Chow KM, Szeto CC, Poon P, Lau WY, Lai FM, Li PK. Transforming growth factor-beta1 gene polymorphism in renal transplant recipients. Ren Fail 2005; 27:671675.
  • 14
    Mehta RL, Kellum JA, Shah SV et al., Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
  • 15
    Englberger L, Suri RM, Li Z et al. Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care 2011; 15:R16.
  • 16
    K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 Suppl. 1):S1–266.
  • 17
    Gustincich S, Manfioletti G, Del Sal G, Schneider C, Carninci P. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991; 11:298300, 302.
  • 18
    Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94:31953199.
  • 19
    Pappachan JV, Coulson TG, Child NJ et al. Mortality in adult intensive care patients with severe systemic inflammatory response syndromes is strongly associated with the hypo-immune TNF -238A polymorphism. Immunogenetics 2009; 61:657662.
  • 20
    Ferrari GL, Quinto BMR, Queiroz KCBS et al. Effects of simvastatin on cytokines secretion from mononuclear cells from critically ill patients with acute kidney injury. Cytokine 2011; 54:144148.
  • 21
    Adib-Conquy M, Adrie C, Moine P, Asehnourne K, Fitting C, Pinsky MR. NF-B expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am J Respir Crit Care Med 2000; 162:18771883.
  • 22
    Ware CF. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 2005; 23:787819.
  • 23
    Elahi MM, Asotra K, Matata BM, Mastana SS. Tumor necrosis factor alpha −308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 2009; 1792:163172.
  • 24
    Lu JC, Coca SG, Patel UD, Cantley L, Parikh CR, Translational Research Investigating Biomarkers and Endpoints for Acute Kidney Injury (TRIBE-AKI) Consortium. Searching for genes that matter in acute kidney injury: a systematic review. Clin J Am Soc Nephrol 2009; 4:10201031.
  • 25
    Marino MW, Dunn D, Grail M et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci USA 1997; 94:80938098.
  • 26
    Jaber BL, Rao M, Guo D et al. Cytokine gene promoter polymorphisms and mortality in acute kidney injury. Cytokine 2004; 25:212219.
  • 27
    Balakrishnan VS, Guo D, Rao M et al., HEMO Study Group. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin. Kidney Int 2004; 65:14491460.
  • 28
    Gallagher PM, Lowe G, Fitzgerald T et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax 2003; 58:154156.
  • 29
    Pelletier R, Pravica V, Perrey C et al. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney–pancreas transplantation. Transplantation 2000; 70:674680.
  • 30
    Watanabe E, Hirasawa H, Oda S et al. Cytokine-related genotypic differences in peak interleukin-6 blood levels of patients with SIRS and septic complications. J Trauma 2005; 59:11811189.